526445
INDRANIB
Start SIP
Invest Now
Start SIP in INDRANIB
Performance
- Low
- ₹13
- High
- ₹14
- 52 Week Low
- ₹10
- 52 Week High
- ₹38
- Open Price₹13
- Previous Close₹13
- Volume45,906
Investment Returns
- Over 1 Month -9.03%
- Over 3 Month + 0.7%
- Over 6 Month -6.72%
- Over 1 Year -63.69%
Smart Investing Starts Here Start SIP with Indrayani Biotech for Steady Growth!
Indrayani Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -7.7
- PEG Ratio
- 0
- Market Cap Cr
- 59
- P/B Ratio
- 0.8
- Average True Range
- 0.89
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.2
- RSI
- 34.68
- MFI
- 32.64
Indrayani Biotech Financials
Indrayani Biotech Technicals
EMA & SMA
Current Price
₹12.90
-0.43
(-3.23%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹13.70
- 50 Day
- ₹13.88
- 100 Day
- ₹14.32
- 200 Day
- ₹17.77
Resistance and Support
13.16
- R3 14.35
- R2 14.02
- R1 13.49
- S1 12.63
- S2 12.30
- S3 11.77
Indrayani Biotech Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-12-11 | Quarterly Results | |
| 2025-08-30 | Others | Inter-alia, to consider 1. Notice of the 33rd AGM of the Company. 2. Appointment of Mr. Swaminathan & Mr. Singarababu Indirakumar as Whole-Time Director. 3. Other business matters. |
| 2025-08-14 | Quarterly Results | |
| 2025-06-12 | Audited Results | (Revised) |
| 2025-04-03 | Rights issue of Equity Shares |
Indrayani Biotech F&O
About Indrayani Biotech
- NSE Symbol
- INDRANIB
- BSE Symbol
- 526445
- Managing Director
- Mr. Kasiraman Sayee Sundar
- ISIN
- INE007C01021
Similar Stocks to Indrayani Biotech
Indrayani Biotech FAQs
Indrayani Biotech share price is ₹12 As on 27 December, 2025 | 01:55
The Market Cap of Indrayani Biotech is ₹58.7 Cr As on 27 December, 2025 | 01:55
The P/E ratio of Indrayani Biotech is -7.7 As on 27 December, 2025 | 01:55
The PB ratio of Indrayani Biotech is 0.8 As on 27 December, 2025 | 01:55
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.